Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma

Clinical trial NCT03656835 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03656835
Sponsor: Ohio State University Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High Grade B-Cell Lymphoma

Start date: 2018-09-26
Primary completion: 2024-11-20
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.